Oramed Pharmaceuticals Inc (ORMP)

[stocktrademan]

$ORMP recent news/filings

bullish
moving average breakout
second mouse gets the cheese

## source: finance.yahoo.com

Mon, 13 Apr 2015 17:19:22 GMT ~ Nasdaq stocks posting largest percentage increases

[AP] - A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: Tonix Pharma rose 26.5 percent to $7.40. Trillium Therapeutic rose 16.4 percent to $11.12. Ebix Inc. rose 14.3 percent to ...

read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220237991--finance.html
*********************************************************

Mon, 13 Apr 2015 17:19:22 GMT ~ Nasdaq stocks posting largest percentage increases

[AP] - A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: Tonix Pharma rose 26.5 percent to $7.40. Trillium Therapeutic rose 16.4 percent to $11.12. Ebix Inc. rose 14.3 percent to ...

read full: http://finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-230628770.html
*********************************************************

Fri, 03 Apr 2015 12:04:11 GMT ~ ORAMED PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report


read full: http://biz.yahoo.com/e/150403/ormp10-q.html
*********************************************************

Thu, 02 Apr 2015 07:03:34 GMT ~ Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin

[at noodls] - JERUSALEM, April 1, 2015 /PRNewswire/ - Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, ...

read full: http://www.noodls.com/view/7D6529B3607568C97C5EC2FC1EDCE34EDFBCED90
*********************************************************

Wed, 01 Apr 2015 14:06:00 GMT ~ Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin

[PR Newswire] - Oramed Pharmaceuticals Inc. (ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the first patient has been enrolled in its Glucose Clamp Study. The study will be performed at The University of Texas Health Science Center at San Antonio and University Health System's Texas Diabetes Institute under the supervision of Professor Ralph DeFronzo. The glucose clamp is a method for quantifying insulin absorption in order to measure a patient's insulin sensitivity and how well a patient metabolizes glucose. We are additionally excited at the prospects of starting our larger Phase IIb trial in the near term. The data from the two trials will allow for a clearer picture of our oral insulin and its pharmacological characteristics as we move forward with our development plan," stated Oramed CEO Nadav Kidron.

read full: http://finance.yahoo.com/news/oramed-enrolls-first-patient-glucose-140600893.html
*********************************************************

$ORMP charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$ORMP company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ORMP/company-info
Ticker: $ORMP
OTC Market Place: Not Available
CIK code: 0001176309
Company name: Oramed Pharmaceuticals, Inc.
Company website: http://www.oramed.com
Incorporated In: DE, USA

Business Description: Oramed Pharmaceuticals (OTC:ORMP.OB) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an oral insulin capsule currently in Phase 2 trials, the Company is seeking to revolutionize the treatment of diabetes.

$ORMP share structure

## source: otcmarkets.com

Market Value: $67,433,165 a/o Apr 10, 2015
Shares Outstanding: l PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">; OTC Markets | Official site of the OTCQX, OTCQB and OTC Pink Marketplaces featuring Free Stock & Bond Quotes, Trade Prices, Chart, Financials and Company News & Information for Investors, Companies and Traders - OTCMarkets.com var appSection = "" ; var tierGroupId = undefined; var symbol = "ORMP"; var jq191 = $.noConflict(true); var appNav = new OTCMarketsAppNav(); var iqCaller = new OtcIQCalls(); var commonCaller = new PinkCommonCalls(); var contentCaller = new PinkContentCalls(); var edgarCaller = new PinkEdgarCalls(); var decorateSymbols = new SymbolDecorator(commonCaller); height="0" width="0" style="display:none;visibility:hidden"> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer',"GTM-N65JXN"); OTC Markets Home Marketplaces Market Activity Current Market Closing Summary Broker Dealer Data Corporate Actions Short Sale Data Reg SHO Data News Company News & Financials Press Releases Videos & Presentations RSS Feeds OTC Markets Events OTC Markets Newsletter OTC Markets Press Center Services Companies Investors Market Data Trading Research Stock Screener OTCQX Company List Company Directory Service Provider Directory OTCQX Advisor List Broker Dealer Directory Prohibited Attorney List Symbology Glossary Learn Our Marketplaces Market 101 Investor Protection Reporting Requirements American Depositary Receipts (ADRs) Apply for OTCQX - Our Best Marketplace Comply with New OTCQB Requirements Information for OTC Pink Companies How to Get Traded Caveat Emptor Policy FINRA & SEC Rules Whitepapers FAQs tierTitle = getTierTitle(undefined); Company Directory | Stock Screener OTC Market Totals - Securities - Dollar Volume - Share Volume - Trades var glossaryDecorator = new GlossaryDecorator (contentCaller) ; $('p').each (function () { var glossaryId = $(this).attr('glossaryId'); if (glossaryId) this.psGlossaryId=glossaryId; }); if (document.getElementById('p')) glossaryDecorator .doSection (document.getElementById ('p')); $('#quoteEntry input#quoteBox').focus(function() { toggleFieldValue(this, 'Enter Symbol/Company Name', ''); }).blur(function() { toggleFieldValue(this, '', 'Enter Symbol/Company Name'); }); var security = new SecurityInfo(213015, 653485, "Oramed Pharmaceuticals, Inc.", "ORAMED PHARMS INC NEW", "ORMP", "Nasdaq", false, false, undefined, "Common Stock", undefined, undefined, false, false, true, false, 0.001000000000000, "0.001", undefined, false, 1.0, undefined); var symbolSecurity = (security.symbol)? security.symbol:security.secId; var initNewsId = undefined; var glossaryDecorator = new GlossaryDecorator (contentCaller) ; Quote Charts Company Profile News Financials Filings and Disclosure Short Sales Insider Disclosure Research Reports Videos and Presentations ORMP Oramed Pharmaceuticals, Inc. Common Stock Nasdaq function doOTCQX30Logo(url) { var CONSTITUENTS_DATA; if ($.browser.msie) { var http = new XDomainRequest(); http.open("get", url); http.onload = function() { var data = http.responseText; if (typeof data === "undefined") return; CONSTITUENTS_DATA = JSON.parse(data); displayIndexLogo(CONSTITUENTS_DATA); }; http.send(null); } else { $.ajax({ type : "GET", url : url, data : {}, success : function(data) { if (typeof data === "undefined") return; CONSTITUENTS_DATA = JSON.parse(data); displayIndexLogo(CONSTITUENTS_DATA); } }); } } function displayIndexLogo(constituents) { if (typeof constituents === undefined) { if (console && console.log) { console.log("Unable to load constituents."); } } var result = $.grep(constituents, function(e){ return e.ticker == security.symbol; }); if (result.length > 0) { $('.tierLogoContainer a').attr('href', '/index/.OTCQX30/quote'); $('.tierLogo').attr('src', '/content/doc/otcm/tier/logo/small/otcqx30.png'); $('.tierLogo').attr('alt','OTCM QX ADR 30 Index Constituent'); $('.tierLogo')[0].psGlossaryId='otcqx30-constituent'; handler.decorateGlossary(); } } var json_url = "http://s3.amazonaws.com/content.otcmarkets.com/constituents/otcqx_30_list.json";; doOTCQX30Logo(json_url); var handler = new QuoteHandler(); handler.checkCaveat(); var tradeHeaderHandler; if (!window.location.href.match('quote')) tradeHeaderHandler = new TradeHeaderHandler(iqCaller, window.document.getElementById('quoteBar')); if (security.symbol == null || security.symbol.length == 0) { $('#quoteUnderArrowTabs li.eqOnly').hide(); } $('img').each(function () { var glossaryId = $(this).attr('glossaryId'); if (glossaryId) this.psGlossaryId = glossaryId; }); handler.decorateGlossary(); $("#title").html('Company Info'); var shortDesc = undefined; var longDesc = "Oramed Pharmaceuticals (OTC:ORMP.OB) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an oral insulin capsule currently in Phase 2 trials, the Company is seeking to revolutionize the treatment of diabetes."; function toggleFullDescription(full) { if (full) { $("#businessContent p").html(longDesc); }else { $("#businessContent p").html(shortDesc); } } Contact Info Hi-Tech Park 25 Givat Ram PO Box 39098 Jerusalem 91390 Israel Website: http://www.oramed.com Phone: [phone] Email: [e-mail] Business Description toggleFullDescription(true); Update Company Profile Financial Reporting/Disclosure Reporting Status U.S. Reporting: SEC Filer
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001

$ORMP extra dd links

Company name: Oramed Pharmaceuticals, Inc.
Company website: http://www.oramed.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ORMP+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ORMP+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ORMP+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ORMP/news - http://finance.yahoo.com/q/h?s=ORMP+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ORMP/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ORMP/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ORMP+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ORMP
DTCC (dtcc.com): http://search2.dtcc.com/?q=Oramed+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Oramed+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Oramed+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.oramed.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.oramed.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.oramed.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ORMP
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001176309&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ORMP/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ORMP/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ORMP&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ORMP
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ORMP/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ORMP+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ORMP+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ORMP
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ORMP
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ORMP+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ORMP/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ORMP+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ORMP.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ORMP
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ORMP/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ORMP/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ORMP
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ORMP
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ORMP:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ORMP
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ORMP



$ORMP DD Notes ~ http://www.ddnotesmaker.com/ORMP